The total return over the past 12 months is +27.88% vs. +16.94% for the S&P 500. So far it's up +48.37% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +27.88% | +4.52% | (16.52%) | +25.17% | +21.85% | N/A |
| Total Return CAGR | +27.88% | +4.52% | (16.52%) | +25.17% | +21.85% | N/A |
| Revenue CAGR | +58.91% | +43.64% | +53.77% | N/A | N/A | N/A |
| Net Income CAGR | +60.53% | (4.73%) | N/A | N/A | N/A | N/A |
| EPS CAGR | +56.15% | (22.80%) | (15.06%) | N/A | N/A | N/A |
| Free Cash Flow CAGR | +30.68% | +37.35% | +18.35% | N/A | N/A | N/A |
| Operating Cash Flow CAGR | +34.75% | +28.66% | +19.95% | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Astrana Health, Inc. (ASTH)
| Year | Start price | End price | ASTH Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $24.81 | $36.81 | +48.37% | +14.51% | +33.86% |
| 2025 | $31.53 | $24.81 | (21.31%) | +17.72% | (39.03%) |
| 2024 | $38.30 | $31.53 | (17.68%) | +24.89% | (42.57%) |
| 2023 | $29.59 | $38.30 | +29.44% | +26.19% | +3.25% |
| 2022 | $73.48 | $29.59 | (59.73%) | (18.17%) | (41.56%) |
| 2021 | $18.27 | $73.48 | +302.19% | +28.74% | +273.45% |
| 2020 | $18.41 | $18.27 | (0.76%) | +18.37% | (19.13%) |
| 2019 | $19.85 | $18.41 | (7.25%) | +31.22% | (38.47%) |
| 2018 | $24.00 | $19.85 | (17.29%) | (4.56%) | (12.73%) |
| 2017 | $7.50 | $24.00 | +220.00% | +21.70% | +198.30% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
